Cannell & Co’s NEVRO CORP. NVRO Stock Holding History

Cannell & Co’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,410	Closed	-$252K	–	263
2016 Q3	$252K	Buy	+2,410	New	+$218K	0.01%	241

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Cannell & Co's NVRO Position: Q4 2016 in Review

Cannell & Co sold out of NEVRO CORP. (NVRO) in Q4 2016, closing a stake of 2,410 shares — an estimated $252K sold.

Cannell & Co first reported a position in NVRO in Q3 2016 and held it in 1 quarter. The position peaked at $252K in Q3 2016. 174 funds tracked by Wall St. Rank hold NVRO as of Q4 2016.

Cannell & Co reported no remaining NEVRO CORP. position as of Q4 2016 after selling out during the quarter.
Cannell & Co sold 2,410 NEVRO CORP. shares in Q4 2016, an estimated $252K.
Cannell & Co first reported a position in NEVRO CORP. in Q3 2016 and held it in 1 quarter.
Cannell & Co's NEVRO CORP. position peaked at $252K in Q3 2016.
174 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2016.

Based on Cannell & Co's 13F filing for Q4 2016, filed 13 Feb 2017.